A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

被引：0
|
作者：
Steven J. Cohen
Mark M. Zalupski
Manuel R. Modiano
Paul Conkling
Yehuda Z. Patt
Peg Davis
Robert T. Dorr
Michelle L. Boytim
Evan M. Hersh
机构：
[1] Fox Chase Cancer Center,Department of Medical Oncology
[2] University of Michigan,undefined
[3] Arizona Clinical Research Center,undefined
[4] Virginia Oncology Associates,undefined
[5] US Oncology Phase I Group,undefined
[6] University of New Mexico,undefined
[7] University of Arizona,undefined
[8] AmpliMed Corporation,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 66卷
关键词：
Gemcitabine; Imexon; Pancreatic cancer; Phase I clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：287 / 294
页数：7
相关论文
共 50 条
  • [41] Carboplatin plus paclitaxel in the first-line treatment of advanced ovarian cancer: Preliminary results of a phase I study
    Lhomme, C
    Kerbrat, P
    Lejeune, C
    Guastalla, JP
    Fumoleau, P
    Goupil, A
    Heron, JF
    Cassin, MA
    Pruvot, I
    Soares, JA
    Chazard, M
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 48 - 54
  • [42] Sindilimab combined with nab-paclitaxel plus gemcitabine as first-line treatment for patients with advanced pancreatic cancer.
    Zhu, Huayun
    Sun, Xiaofeng
    Pan, Xuan
    Wu, Pingping
    Chen, Jia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study
    Colucci, Giuseppe
    Labianca, Roberto
    Di Costanzo, Francesco
    Gebbia, Vittorio
    Carteni, Giacomo
    Massidda, Bruno
    Dapretto, Elisa
    Manzione, Luigi
    Piazza, Elena
    Sannicolo, Mirella
    Ciaparrone, Marco
    Cavanna, Luigi
    Giuliani, Francesco
    Maiello, Evaristo
    Testa, Antonio
    Pederzoli, Paolo
    Falconi, Massimo
    Gallo, Ciro
    Di Maio, Massimo
    Perrone, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (10) : 1645 - 1651
  • [44] Use of first-line chemotherapy for advanced pancreatic cancer: FOLFIRINOX versus gemcitabine-based therapy.
    Cartwright, Thomas H.
    Ginsburg, Aimee
    Wilfong, Lalan S.
    Harrell, Robyn K.
    Hoverman, J. Russell
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [45] Phase I study of docetaxel, oxaliplatin, and capecitabine as first-line therapy to patients with advanced gastroesophageal cancer
    Schonnemann, K. R.
    Andersen, M.
    Yilmaz, M.
    Jensen, H. A.
    Vestermark, L. W.
    Pfeiffer, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] Use of first-line chemotherapy for advanced pancreatic cancer: FOLFIRINOX versus gemcitabine.
    Arlen, Aimee Ginsburg
    Cartwright, Thomas H.
    Wilfong, Lalan S.
    Hoverman, J. Russell
    Nelson, Greg C.
    Turnwald, Brian
    Beveridge, Roy A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer
    Yip, D
    Goldstein, D
    CANCER TREATMENT REVIEWS, 2005, 31 (03) : 236 - 241
  • [48] Biweekly Gemcitabine/Nab-Paclitaxel as First-line Treatment for Advanced Pancreatic Cancer
    Kokkali, Stefania
    Tripodaki, Elli-Sophia
    Drizou, Maria
    Stefanou, Dimitra
    Magou, Elpida
    Zylis, Dimosthenis
    Kapiris, Matthaios
    Nasi, Despoina
    Georganta, Chara
    Ardavanis, Alexandros
    IN VIVO, 2018, 32 (03): : 653 - 657
  • [49] Updated use of first-line chemotherapy for advanced pancreatic cancer: FOLFIRINOX versus gemcitabine
    Cartwright, Thomas H.
    Arlen, Aimee Ginsburg
    Wilfong, Lalan S.
    Harrell, Robyn K.
    Hoverman, J. Russell
    Beveridge, Roy A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [50] First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer
    Vaccaro, Vanja
    Bria, Emilio
    Sperduti, Isabella
    Gelibter, Alain
    Moscetti, Luca
    Mansueto, Giovanni
    Ruggeri, Enzo Maria
    Gamucci, Teresa
    Cognetti, Francesco
    Milella, Michele
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (28) : 4511 - 4519
12345